✦ LIBER ✦

Adverse Event Management of mTOR Inhibitors During Treatment of Hormone Receptor–Positive Advanced Breast Cancer: Considerations for Oncologists

✍ Scribed by Yardley, Denise A.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Management of adverse events in patients

✍ Mary E. Peterson 📂 Article 📅 2013 🏛 Springer-Verlag 🌐 English ⚖ 256 KB

NICE guidance on everolimus in combinati

✍ Burke, Martyn J; Garrett, Zoe; George, Elisabeth; Adler, Amanda I 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 53 KB

PCN59 Patterns of Clinical Management an

✍ F. Andre; N. Marinsek; J.F. Ricci; J. Etchberger; R. Degun; G. Benelli; S. Salet 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 63 KB

Lapatinib or trastuzumab in combination

✍ Sally Doss; Janet Robertson; Jane Adam 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 42 KB

An Indirect Treatment Comparison of the

✍ Chandiwana, D.; Vieira, J.; Granville, J.; McCool, R.; Fleetwood, K. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB

A randomized, double-blind, controlled s

✍ Iwata, Hiroji; Masuda, Norikazu; Ohno, Shinji; Rai, Yoshiaki; Sato, Yasuyuki; Oh 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 315 KB